Daniel Brinkmann, Waverly, medical debt collection.
Absolute Investments LLC v.
Merchants Acceptance Corp., Bellevue, Washington, v.
Michael and Tori Batton, Janesville, retail purchase debt collection.
OneMain Financial Group Inc., Evansville, Indiana, v.
Anthony Skaggs, Waverly, personal loan debt collection.
Credit Bureau Services of Iowa Inc., Oskaloosa, v.
Laren L. Ensign, Tripoli, medical debt collection.
Hauge Associates Inc., Sioux Falls, South Dakota, v.
Kevin C. Katzenburger, Tripoli, medical debt collection.
LVNV Funding LLC v.
State of Iowa v.
State of Iowa v.
State of Iowa v.
State of Iowa v.
DISTRICT COURT
State of Iowa v.
Steven James Cooper, 60, Waterloo, pled guilty to operating motor vehicle without ownerâs consent, sentenced to up to two years in prison, suspended, fine of $625 also suspended, all financial obligations are payable in installments of at least $50 every 30 days, unable to pay attorneyâs fee, placed on probation f
Search jobs 16-Dec-2020 First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis with polyangiitis
New clinical trial also announced for Fasenra
in eosinophilic gastritis/eosinophilic gastroenteritis
The first patients have been dosed in
Fasenra (benralizumab) Phase III trials in three rare eosinophilic diseases: hypereosinophilic syndrome (HES), eosinophilic esophagitis (EoE) and eosinophilic granulomatosis with polyangiitis (EGPA)
AstraZeneca will also initiate a Phase III trial to investigate the potential of
Fasenra in an additional rare eosinophilic disease: eosinophilic gastritis/eosinophilic gastroenteritis (EG/EGE). This trial extends the
Fasenra clinical programme to nine diseases where eosinophils play an important role, in addition to severe asthma.